Oklo Stock Declines Following Launch Of $1B Share-Sale Program

Oklo (OKLO) shares fell over 7% after announcing a $1b at-the-market stock offering. The stock has declined 9.18% in one day, 18.39% in 30 days, and 53.44% year-to-date, though it has seen significant gains over 3 and 5 years. The company, which focuses on modular nuclear reactors and long-term electricity contracts, faces execution and regulatory risks, including a prior license denial. Analysts peg its fair value at $80.55, significantly above its recent close of $36.22.

Shares of NuScale Power (SMR), Oklo (OKLO), and Nano Nuclear Energy (NNE) rose in pre-market trading after EPA Administrator Lee Zeldin highlighted small modular reactors as key to U.S. energy dominance. Zeldin's comments align with Trump's executive order to streamline nuclear regulations. SMR gained 5%, while OKLO and NNE each rose 2%.

Vistra (VST) and NRG (NRG) rose 0.9% and 1.6% respectively, while NuScale (SMR) fell 15.8% after UBS downgraded it, citing delays and financial risks. UBS questioned NuScale's commercialization timeline and customer commitments, leading to a broader nuclear sector selloff. Vistra and NRG benefited from their current earnings and diversified power strategies.

Oklo Inc. (OKLO) shares fell 2% on Wednesday and declined further overnight. Piper Sandler initiated coverage with an 'Overweight' rating and $55 price target, citing 29% upside. The analyst noted bipartisan support for nuclear energy and Meta's (META) recent deal with Oklo. Retail sentiment on Stocktwits was bearish. OKLO has a 12-month average price target of $78.69, with 16 of 26 analysts rating it 'Buy' or higher.

Oklo Inc. (OKLO) shares dropped 7.17% after announcing a $1 billion equity program to sell Class A common stock. The program, facilitated by multiple banks, replaces a prior agreement where Oklo sold 17.97 million shares for $1 billion. Proceeds will support corporate purposes and investments. The stock trades around $37, which would dilute existing holders by about 14.6%.

OKLO stock fell due to a $1 billion equity distribution agreement allowing the company to sell shares, risking dilution. The company plans to use funds for its Aurora reactors. Barchart rates it '100% SELL', citing high risk and long commercialization timelines. Insiders sold shares, with no purchases. Wall Street maintains a 'Moderate Buy' consensus, with a $80 price target.